By: James A. Wolff, Esq. and David Egozi*, Summer Associate (*Not an Attorney)
A central policy focus of the reauthorization is addressing the long-standing “Valley of Death” between Phase II development and Phase III commercialization. While the introduction of Strategic Breakthrough Awards is one response, the legislation also places greater emphasis on measurable commercialization outcomes.
For startups, this shift has practical legal implications. Companies must position themselves not only as research performers but as viable commercial partners capable of transitioning technology into operational use. This often involves entering into agreements with prime contractors, strategic partners, or government end-users, each of which introduces additional layers of contractual and regulatory complexity.
Key considerations include:
- Teaming Agreements and Subcontracts: Properly structuring relationships with larger defense contractors or integrators while maintaining compliance with small business requirements.
- Flow-Down Provisions: Ensuring that subcontract terms do not impose obligations inconsistent with SBIR/STTR protections or small business status.
- Intellectual Property Carve-Outs: Preserving ownership of core technology while granting limited rights necessary for integration or deployment.
The reauthorization’s focus on commercialization metrics may also influence how agencies evaluate proposals and allocate funding, increasing the importance of credible transition plans and legally sound partnership structures.
Compliance Infrastructure and Internal Controls
As reporting requirements and agency oversight expand, startups must treat SBIR/STTR participation as a regulated activity rather than a purely opportunistic funding source. This includes implementing internal processes to manage eligibility certifications, reporting obligations, and audit readiness.
Areas requiring particular attention include:
- Organizational Documentation: Maintaining accurate and up-to-date records of ownership, governance, and affiliations.
- Conflict of Interest Policies: Addressing potential overlaps between academic institutions, founders, and affiliated entities (particularly in STTR arrangements).
- Export Controls and Data Security: Evaluating whether funded research implicates International Traffic in Arms Regulations (ITAR) or Export Administration Regulations (EAR), and implementing safeguards accordingly.
Given the increasing intersection between SBIR/STTR participation and national security policy, companies should anticipate a more rigorous compliance environment, particularly for technologies deemed sensitive or strategically significant.
This is part two of a new three-part blog series, in which partner James Anthony Wolff and summer associate David Egozi examine the legal and structural implications of the 2026 SBIR/STTR reauthorization
